Sunday, 21 April 2024
Corcept Therapeutics Incorporated
The results here are provided for general informational purposes, as a convenience to the readers. The materials are not a substitute for obtaining professional advice from a qualified person, firm or corporation.
more»
10:22 | 6/3/18
Frisco Fastball
Investors sentiment decreased to 1.96 in Q3 2017. Its down 0.47, from 2.43 in 2017Q2. It dived, as 13 investors sold CORT shares while 39 reduced holdings.
more»
04:22 | 6/3/18
Newberry Journal
Wall Street analysts often give recommendations on equities that they cover. These analysts typically have a deep understanding of the health of a particular company.
more»
03:37 | 6/3/18
StockNewsJournal
Investors who are keeping close eye on the stock of Corcept Therapeutics Incorporated (NASDAQ:CORT) established that the company was able to keep return on investment at 139.75 in the trailing twelve month while Reuters data showed that industry's ...
more»
Take Note: Corcept Therapeutics Incorporated (NASDAQ:CORT) has hit some technical weakness in its momentum, and while it has not broken down all the way through support -- watch the key levels that we discuss below and further, watch the stochastics ...
more»
05:41 | 1/3/18
StockNewsJournal
Investors who are keeping close eye on the stock of Corcept Therapeutics Incorporated (NASDAQ:CORT) established that the company was able to keep return on investment at - in the trailing twelve month while Reuters data showed that industry's average ...
more»
Risk Alert: Before we dive into any analysis we simply note that Corcept Therapeutics Incorporated (NASDAQ:CORT) risk is elevated.
more»
11:30 | 27/2/18
Equities.com
Corcept Therapeutics Incorporated (CORT) had a rough trading day for Monday February 26 as shares tumbled 5.52%, or a loss of $-0.91 per share, to close at $15.57.
more»
10:00 | 23/2/18
GlobeNewswire
MENLO PARK, Calif., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ:CORT), a company engaged in the discovery, development and commercialization of drugs to treat severe metabolic, oncologic and psychiatric disorders by ...
more»
03:48 | 23/2/18
Simply Wall St
The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. If you don't agree with my result, have a go at the calculation yourself and play with the assumptions.
more»
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |